Edgewise Therapeutics (EWTX) revenue

There is no revenue history on record here for Edgewise Therapeutics (EWTX). Figures as of 18 Nov 2026, 09:52 UTC, from the company's filings with the SEC and Yahoo Finance.

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Not enough data

A history of revenue needs at least 3 fiscal years; none is on record here for Edgewise Therapeutics. Nothing is estimated to fill the gap.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of Edgewise Therapeutics and comparable companies
CompanyRevenueFiscal year
Concentra Group Holdings Parent CON$2.16B2025
Merit Medical Systems MMSI$1.52B2025
LivaNova LIVN$1.39B2025
Ionis Pharmaceuticals IONS$943.71M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on EWTX

Edgewise Therapeutics, figure by figure

Edgewise Therapeutics (EWTX) overview: price, valuation and scorecardAll health care companies by market value

Edgewise Therapeutics revenue: questions and answers

How is Edgewise Therapeutics's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Edgewise Therapeutics (EWTX) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/EWTX/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.